По вашему запросу найдено документов: 150

Страница 3 из 15

Long noncoding RNAs as promising biomarkers in cancer: long non-coding RNAs and cancer
Beylerli, O., Gareev, I., Sufianov, A., Ilyasova, T., Guang, Y. (2022)
Despite many advances in diagnosis and therapy (surgery, radiation therapy, chemotherapy), cancer
Myeloid differential protein-2 inhibition improves diabetic cardiomyopathy via p38MAPK inhibition and AMPK pathway activation
Qian, J., Zhuang, F., Chen, Y., Fan, X., Wang, J., Wang, Z., Wang, Y., Xu, M., Samorodov, A.V., Pavlov, V.N., Liang, G. (2022)
MD2 a promising target for DCM treatment by suppressing metaflammation and improving cardiac
Возможности применения комбинации ленватиниба и пембролизумаба при распространенной эндометриальной карциноме
Possible applications for combined lenvatinib and pembrolizumab in advanced endometrial carcinoma
К. В. Меньшиков, K. V. Menshikov, А. В. Султанбаев, A. V. Sultanbaev, Ш. И. Мусин, Sh. I. Musin, И. А. Меньшикова, I. A. Menshikova, Н. И. Султанбаева, N. I. Sultanbaeva, А. А. Измайлов, A. A. Izmailov, А. А. Фатихова, A. A. Fatikhova, Д. О. Липатов, D. O. Lipatov, Г. А. Серебренников, G. A. Serebrennikov (Креативная хирургия и онкология, №4, 2022)
Применение новой биологической патогенетической терапии мигрени в клинической практике: консенсус экспертов Российского общества по изучению головной боли
Application of a new biological pathogenetic therapy of migraine in clinical practice: expert consensus of the Russian Headache Research Society
Sergeev, A.V., Tabeeva, G.R., Filatova, E.G., Amelin, A.V., Akhmadeeva, L.R., Lebedeva, E.R., Osipova, V.V., Azimova, Yu.E., Latysheva, N.V., Doronina, O.B., Skorobogatykh, K.V., Сергеев А.В., Табеева Г.Р., Филатова Е.Г., Амелин А.В., Ахмадеева Л.Р., Лебедева Е.Р., Осипова В.В., Азимова Ю.Э., Латышева Н.В., Доронина О.Б., Скоробогатых К.В. (2022)
Application of a new biological pathogenetic therapy of migraine in clinical practice: expert
Circular RNAs as biomarkers and therapeutic targets in cancer
Beilerli, A., Gareev, I., Beylerli, O., Yang, G., V.N. Pavlov, Aliev, G., Ahmad, A. (2022)
discuss the possibility of using circRNAs as potential therapeutic targets and biomarkers for cancer.
Role of retroelements in the development of COVID-19 neurological consequences
Mustafin, Rustam N., Kazantseva, Anastasiya V, Kovas, Yulia V, Khusnutdinova, Elza K (2022)
for developing targeted therapy for neurological consequences of COVID-19 using miRNAs, since epigenetic changes
Genetic Predisposition to Schizophrenia and Depressive Disorder Comorbidity
Shnayder, N.A., Novitsky, M.A., Neznanov, N.G., Limankin, O.V., Asadullin, A.R., Petrov, A.V., Dmitrenko, D.V., Narodova, E.A., Popenko, N.V., Nasyrova, R.F. (2022)
the presentation of comorbid depression in schizophrenia. The molecular mechanisms linking schizophrenia
Thioterpenoids as Potential Antithrombotic Drugs: Molecular Docking, Antiaggregant, Anticoagulant and Antioxidant Activities
Ksenofontov, Alexander A., Bocharov, Pavel S., Antina, Elena V., Shevchenko, Oksana G., Samorodov, Aleksandr V., Gilfanov, Ilmir R., Pavelyev, Roman S., Ostolopovskaya, Olga V., Startseva, Valeriya A., Fedyunina, Inna V., Azizova, Zulfiya R., Gaysin, Salavat I. (2022)
compounds on platelet aggregation was investigated by using the molecular docking technique. The obtained
Новые взгляды на патогенез и диагностику перитонеального канцероматоза
New views on pathogenesis and diagnosis of peritoneal carcinomatosis
К. Р. Ишмуратова, K. R. Ishmuratova, К. Ш. Ганцев, K. Sh. Gantsev (Креативная хирургия и онкология, №4, 2022)
Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia
Vaiman, E.E., Shnayder, N.A., Zhuravlev, N.M., Petrova, M.M., Asadullin, A.R., Al-Zamil, M., Garganeeva, N.R., Shipulin, G.A., Cumming, G., Nasyrova, R.F. (2022)
of which is influenced by modifying factors (APs’ dose, duration of APs therapy, APs polytherapy

Страница 3 из 15

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год